Abstract
Summary The hypothalamic-pituitary-adrenocortical (hpa) axis was studied in 8 healthy cats after administration of supraphysiologic doses of methylprednisolone (mp). Ovine corticotropin-releasing hormone (oCHR) administration increased cortisol and adrenocorticotropic hormone (acth) concentrations. Significant (P < 0.05) suppression of cortisol and a trend toward suppression of acth was observed after 1 week of mp administration. The hpa axis quickly recovered from suppressive effects of mp 1 week after administration of the steroid was discontinued. Side effects of ocrh administration were minimal in 7 cats; however, 1 cat had a severe hypotensive reaction. Clinical abnormalities were not associated with mp administration. The hpa axis was suppressed by supraphysiologic doses of mp in all treated cats that lacked clinical signs consistent with iatrogenic hpa axis suppression. Despite the relatively active pars intermedia in cats, compared with human beings and dogs, feedback of mp on the hpa axis resulted in similar trends in ocrh-stimulated acth and cortisol concentrations as observed in human beings and dogs. Lack of consistent correlation between acth and cortisol concentrations was observed in 3 cats and possibly was related to the active pars intermedia in the cat.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
